Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,344 | 213 | 97.5% |
| Education | $85.00 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $590.00 | 38 | $0 (2024) |
| Astellas Pharma US Inc | $301.80 | 15 | $0 (2023) |
| Merck Sharp & Dohme LLC | $282.05 | 19 | $0 (2024) |
| Novo Nordisk Inc | $280.69 | 18 | $0 (2024) |
| ABBVIE INC. | $257.91 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $193.98 | 13 | $0 (2024) |
| Amgen Inc. | $170.89 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $161.76 | 11 | $0 (2024) |
| PFIZER INC. | $144.33 | 9 | $0 (2024) |
| Lilly USA, LLC | $137.30 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,323 | 74 | AstraZeneca Pharmaceuticals LP ($256.09) |
| 2023 | $542.48 | 33 | Astellas Pharma US Inc ($104.50) |
| 2022 | $352.62 | 25 | PFIZER INC. ($45.82) |
| 2021 | $531.06 | 32 | Astellas Pharma US Inc ($98.86) |
| 2020 | $43.91 | 3 | Novo Nordisk Inc ($29.96) |
| 2019 | $230.60 | 17 | AstraZeneca Pharmaceuticals LP ($40.99) |
| 2018 | $241.30 | 19 | AstraZeneca Pharmaceuticals LP ($74.44) |
| 2017 | $163.81 | 11 | AstraZeneca Pharmaceuticals LP ($58.38) |
All Payment Transactions
214 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: VACCINES | ||||||
| 12/03/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/02/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Vaccines | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Inflammation | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Oncology | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Obesity | ||||||
| 09/17/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Inflammation | ||||||
| 09/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: VACCINE | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Respiratory | ||||||
| 08/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 388 | 493 | $145,747 | $47,113 |
| 2022 | 12 | 574 | 705 | $200,758 | $66,799 |
| 2021 | 13 | 624 | 754 | $208,479 | $63,217 |
| 2020 | 13 | 723 | 826 | $166,392 | $62,455 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 247 | $98,800 | $22,279 | 22.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 96 | 96 | $22,464 | $13,506 | 60.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $6,864 | $4,214 | 61.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 43 | 45 | $4,185 | $3,145 | 75.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 43 | $2,494 | $1,413 | 56.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 21 | $6,468 | $1,203 | 18.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 13 | 13 | $3,614 | $925.19 | 25.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $858.00 | $427.31 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 302 | $123,816 | $26,604 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 105 | 105 | $24,570 | $15,012 | 61.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 37 | 37 | $10,804 | $9,754 | 90.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 52 | 54 | $5,022 | $3,610 | 71.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 36 | $11,088 | $2,632 | 23.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $5,317 | $2,396 | 45.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 26 | 26 | $7,228 | $2,155 | 29.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 53 | 55 | $3,190 | $1,792 | 56.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 39 | 39 | $2,574 | $1,274 | 49.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $5,454 | $885.47 | 16.2% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 12 | 12 | $720.00 | $519.92 | 72.2% |
| 90471 | Administration of vaccine | Office | 2022 | 15 | 15 | $975.00 | $164.27 | 16.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 179 | 292 | $121,040 | $27,801 | 23.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 115 | 115 | $26,910 | $16,899 | 62.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 84 | 94 | $25,806 | $5,874 | 22.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 52 | 54 | $5,022 | $3,507 | 69.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 19 | 19 | $6,498 | $2,380 | 36.6% |
About Dr. Akshar Patel, D.O
Dr. Akshar Patel, D.O is a Internal Medicine healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2014. The National Provider Identifier (NPI) number assigned to this provider is 1548678246.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Akshar Patel, D.O has received a total of $3,429 in payments from pharmaceutical and medical device companies, with $1,323 received in 2024. These payments were reported across 214 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,344).
As a Medicare-enrolled provider, Patel has provided services to 2,309 Medicare beneficiaries, totaling 2,778 services with total Medicare billing of $239,584. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Camden, NJ
- Active Since 07/25/2014
- Last Updated 08/10/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548678246
Products in Payments
- FARXIGA (Drug) $234.16
- VRAYLAR (Drug) $207.00
- JARDIANCE (Drug) $118.95
- Cologuard Collection Kit (Device) $109.60
- Wegovy (Drug) $100.84
- TRELEGY ELLIPTA (Drug) $100.75
- Otezla (Drug) $91.78
- BREZTRI (Drug) $88.17
- REXULTI (Drug) $87.28
- FREESTYLE LIBRE 3 (Device) $85.19
- BEVESPI AEROSPHERE (Drug) $81.67
- PREVNAR 20 (Biological) $81.39
- Rybelsus (Drug) $77.24
- GARDASIL (Biological) $71.63
- Vio3 APC3 (Device) $70.00
- MYRBETRIQ (Drug) $68.76
- Ozempic (Drug) $66.11
- MOUNJARO (Drug) $65.27
- AIRSUPRA (Drug) $65.10
- Myrbetriq (Drug) $58.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Camden
Andrea Russo, Md, MD
Internal Medicine — Payments: $294,681
Peter Georges, M.d, M.D
Internal Medicine — Payments: $78,843
Dr. Sajjad Sabir, M.d, M.D
Internal Medicine — Payments: $57,782
Wissam Abouzgheib, M.d, M.D
Internal Medicine — Payments: $48,268
Theodore Plush, D.o, D.O
Internal Medicine — Payments: $12,815
Dr. Daniel Tran, Do, DO
Internal Medicine — Payments: $11,940